Yasuhiro Okamoto
Overview
Explore the profile of Yasuhiro Okamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
154
Citations
567
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawano T, Sugita K, Masuya R, Nishida N, Nagano A, Murakami M, et al.
Diseases
. 2025 Feb;
13(2).
PMID: 39997047
Advances in treatment have dramatically improved the outcomes of pediatric renal malignancies. We reviewed cases of renal malignant tumors that were managed in our institution. The patients' background factors, pathological...
2.
Kawamura J, Yamakuchi M, Ueno K, Hashiguchi T, Okamoto Y
Sci Rep
. 2025 Feb;
15(1):4138.
PMID: 39900983
The detailed mechanism of pulmonary arteriovenous malformations after Glenn surgery (G-PAVMs) in cyanotic congenital heart disease (CHD) remains unclear. Microarray in situ hybridization was performed to assess the miRNA (miRNA)...
3.
Shimozono T, Ueno K, Okuda E, Takahashi Y, Nakae K, Kawamura J, et al.
Cureus
. 2024 Dec;
16(11):e74658.
PMID: 39735129
Background Children with Down syndrome (DS) often have hypoplastic kidneys and urinary tract malformations that increase their renal dysfunction risk. They also have a higher congenital heart disease (CHD) rate,...
4.
Beppu S, Nishikawa T, Tomomasa D, Hijikata A, Kasabata H, Terazono H, et al.
Front Immunol
. 2024 Dec;
15:1478411.
PMID: 39635533
Background: Newborn screening (NBS) for severe combined immunodeficiency (SCID) has improved the prognosis of SCID. In Japan, NBS testing (measurement of the T-cell receptor excision circles (TREC) and kappa-deleting recombination...
5.
Tokunaga M, Seki Y, Horiguchi T, Miura K, Kakimoto H, Morita S, et al.
Endocr J
. 2024 Nov;
72(3):319-323.
PMID: 39566961
Liddle syndrome (LS) is an autosomal dominant genetic disorder characterized by early onset hypertension, hypokalemia, and low plasma aldosterone or renin concentration. It is caused by mutations in subunits of...
6.
Kato M, Okamoto Y, Imamura T, Kada A, Saito A, Iijima-Yamashita Y, et al.
J Clin Oncol
. 2024 Nov;
43(5):567-577.
PMID: 39531610
Purpose: The JCCG ALL-B12 clinical trial aimed to evaluate the effectiveness of unvalidated treatment phases for pediatric ALL and develop a safety-focused treatment framework. Patients And Methods: Patients age 1-19...
7.
Shimonodan H, Sakaguchi K, Ishihara T, Okamoto Y, Nishikawa T, Keino D, et al.
Int J Hematol
. 2024 Sep;
120(6):725-734.
PMID: 39347942
Silent inactivation (SI) of L-asparaginase (ASP) is a phenomenon by which a neutralizing antibody for ASP (AAA) decreases ASP activity (ASA) in patients without a clinical allergy to ASP. Acute...
8.
Sakaguchi H, Taga T, Ishida H, Hama A, Okamoto Y, Sano H, et al.
Bone Marrow Transplant
. 2024 Aug;
59(11):1621-1624.
PMID: 39174743
No abstract available.
9.
Yasudome Y, Nakagawa S, Nagahama J, Nakamura T, Abematsu T, Kodama Y, et al.
Pediatr Blood Cancer
. 2024 Jul;
71(10):e31235.
PMID: 39054692
No abstract available.
10.
Abematsu T, Nishikawa T, Kasabata H, Nakagawa S, Okamoto Y
Cureus
. 2024 Jul;
16(6):e62263.
PMID: 39006644
Blinatumomab, a CD19/CD3 bispecific T-cell engager, is recognized as an effective immunotherapy for relapsed B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However, the efficacy and safety of blinatumomab in post-hematopoietic stem...